4th Quarter - Report
AMGEN, INC. for AMGEN INC
Firm
Client
Income
—
Expenses
$2,410,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Corporate Tax Issues Research and Development Tax Credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| L NICOLE CURRIE | — |
Copyright/Patent/Trademark CPT
Intellectual Property and Process Patent Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN RHEE | — |
Health Issues HCR
Biosimilars H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS | — |
| L NICOLE CURRIE | — |
| RODGER CURRIE | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| SCOTT OLSEN | — |
| HELEN RHEE | — |
Medicare/Medicaid MMM
Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS | — |
| L NICOLE CURRIE | — |
| RODGER CURRIE | — |
| JESSE KERNS | — |
| REBECCA MANDELL | — |
| HOWARD MOON | — |
| WILLIAM O'BRIEN | — |
| SCOTT OLSEN | — |
| HELEN RHEE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.